| 35.42 0.99 (2.88%) | 02-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 42.98 | 1-year : | 50.2 |
| Resists | First : | 36.79 | Second : | 42.98 |
| Pivot price | 34.37  |
|||
| Supports | First : | 33.12 | Second : | 30.86 |
| MAs | MA(5) : | 34.16 |
MA(20) : | 34.83 |
| MA(100) : | 30.71 |
MA(250) : | 31.09 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 49.7 |
D(3) : | 31.9 |
| RSI | RSI(14): 59.5 |
|||
| 52-week | High : | 36.79 | Low : | 24.23 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ OPCH ] has closed below upper band by 17.3%. Bollinger Bands are 12.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 35.49 - 35.74 | 35.74 - 35.94 |
| Low: | 33.93 - 34.19 | 34.19 - 34.39 |
| Close: | 35.07 - 35.48 | 35.48 - 35.81 |
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Sat, 14 Feb 2026
Option Care Health, Inc.'s (NASDAQ:OPCH) Stock Is Going Strong: Is the Market Following Fundamentals? - simplywall.st
Sun, 01 Feb 2026
A Look At Option Care Health (OPCH) Valuation After Recent Mixed Share Price Performance - Yahoo Finance
Thu, 29 Jan 2026
Option Care Health to Participate in the TD Cowen Healthcare Conference - The Globe and Mail
Wed, 28 Jan 2026
Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Wed, 28 Jan 2026
Compass Wealth Management LLC Sells 182,440 Shares of Option Care Health, Inc. $OPCH - MarketBeat
Fri, 23 Jan 2026
Massachusetts Financial Services Co. MA Buys 33,019 Shares of Option Care Health, Inc. $OPCH - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 159 (M) |
| Shares Float | 149 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 105.4 (%) |
| Shares Short | 8,240 (K) |
| Shares Short P.Month | 9,260 (K) |
| EPS | 1.25 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.48 |
| Profit Margin | 3.7 % |
| Operating Margin | 5.8 % |
| Return on Assets (ttm) | 6 % |
| Return on Equity (ttm) | 15 % |
| Qtrly Rev. Growth | 12.1 % |
| Gross Profit (p.s.) | 6.74 |
| Sales Per Share | 34.83 |
| EBITDA (p.s.) | 2.52 |
| Qtrly Earnings Growth | 3.2 % |
| Operating Cash Flow | 259 (M) |
| Levered Free Cash Flow | 174 (M) |
| PE Ratio | 28.11 |
| PEG Ratio | 0 |
| Price to Book value | 4.17 |
| Price to Sales | 1.01 |
| Price to Cash Flow | 21.73 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|